Current Report Filing (8-k)
July 19 2018 - 09:11AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
July 18, 2018
MISONIX,
INC.
(Exact
name of Registrant as specified in its charter)
New
York
|
1-10986
|
11-2148932
|
(State
or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification No.)
|
1938
New Highway, Farmingdale, New York 11735
(Address
of principal executive offices, including zip code)
(631)
694-9555
(Registrant's telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item
5.02.
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers
|
On
July 18, 2018, the Board of Directors of Misonix, Inc. (the “Company”) appointed Gwendolyn A. Watanabe to the Company’s
Board of Directors.
Ms.
Watanabe replaces John W. Gildea, who resigned from his position as a member of the Board of Directors of the Company on July
18, 2018. Mr. Gildea’s decision to resign was not the result of any disagreement with the Company on any matter relating
to the Company’s operations, policies or practices.
In
connection with her appointment, Ms. Watanabe entered into the Company’s previously disclosed standard form of director
Indemnification Agreement. She also received a grant of ten-year stock options to purchase 20,000 shares of Company common stock
at an exercise price of $13.50 per share, vesting in four equal annual installments.
The
Company issued a press release with respect to the foregoing appointment, which is attached hereto as Exhibit 99.1.
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits
– The following exhibit is filed as part of this report:
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
MISONIX, INC.
|
|
|
|
Date: July 19, 2018
|
By:
|
/s/ Stavros
G. Vizirgianakis
|
|
|
Stavros G. Vizirgianakis
|
|
|
Chief Executive Officer
|
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Feb 2024 to Mar 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Mar 2023 to Mar 2024